A 20-year study of more than 65,000 postmenopausal women found that higher adherence to the Planetary Health Diet was associated with a lower risk of overall cardiovascular disease, coronary heart disease, stroke, and heart failure, according to findings from the Women’s Health Initiative. Cardiovascular Risk Reduction Among Postmenopausal Women Researchers following 66,892 participants in the … Read more
The updated ABCs of cardiovascular disease (CVD) prevention framework, published in the American Journal of Preventive Cardiology in 2026, provides a standardized, evidence-based roadmap for clinicians to manage heart health across a patient’s lifespan. By integrating tools like the PREVENT™ risk scoring system and addressing Cardiovascular-Kidney-Metabolic (CKM) syndrome, the framework shifts clinical focus toward early, … Read more
A study published in the journal Scientific Reports reveals that individuals who have contracted SARS-CoV-2 face an increased risk of developing new-onset obstructive sleep apnea (OSA) for up to 4.5 years post-infection. Researchers analyzing electronic medical records from the Montefiore Health System for over 910,000 patients found that COVID-19 infection is independently associated with a … Read more
Researchers have identified the lysosomal ion channel TRPML1 as a critical regulator of mitochondrial stability, offering a potential new therapeutic target to prevent the progression of pathological cardiac hypertrophy into heart failure. A study published in the journal Engineering found that TRPML1 protects heart cells by inhibiting the oligomerization of VDAC1, a protein on the … Read more
Low blood pressure, or hypotension, is linked to a significantly higher risk of developing Alzheimer’s disease, according to a study published in the Journal of the American Heart Association. Researchers analyzing data from nearly 800,000 adults found that individuals with low blood pressure were up to three times more likely to be diagnosed with Alzheimer’s … Read more
Researchers at the Medical University of South Carolina (MUSC) have identified a fundamental defect in the protein repair systems of patients with idiopathic dilated cardiomyopathy (IDCM). According to a 2026 study published in the Journal of Molecular and Cellular Cardiology, this breakdown in cellular maintenance leads to the accumulation of misfolded protein plaques, mirroring processes … Read more
New research published in Nature Medicine reveals that the medication dapagliflozin significantly reduces the risk of heart failure in patients who carry specific cardiomyopathy-associated genetic variants. Findings from the Mass General Brigham Heart and Vascular Institute and the Broad Institute of MIT and Harvard suggest that these genetic markers could help clinicians identify patients who … Read more
The Conclude of the “Baby Aspirin” Era? Why Heart Health is Getting Personal For decades, the daily “baby aspirin” was a staple in the medicine cabinets of millions of older adults. The logic seemed simple: by making blood platelets less sticky, aspirin could theoretically prevent the arterial blockages that lead to heart attacks and strokes. … Read more
The Shift Away from the “One-Size-Fits-All” Aspirin Routine For decades, the daily “baby aspirin” was a staple for older adults aiming to ward off heart attacks and strokes. The logic was simple: make blood platelets less sticky to prevent arterial blockages. However, the medical landscape is shifting rapidly. Recent data from Epic Research reveals a … Read more
The Shifting Landscape of Cardiogenic Shock For decades, the medical community has focused its efforts on ischemic cardiogenic shock (CS)—the sudden, massive heart failure that typically follows a heart attack. This focus has paid off. Data from the CDC WONDER database reveals a steady decline in deaths from heart attack-related CS between 1999 and 2020, … Read more